On May 8th, the makers of the oncotype DX Prostate Cancer Test presented results of a large study demonstrating that their test can help men decide whether their prostate cancer carries a low enough risk of progression to forgo surgical or radiation therapy, two treatments that typically eradicate prostate cancers but also cause most men to…
The Atlantic recently reproduced a figure showing just how much people like things when they are free. Specifically, they looked at health interventions and show that people are more likely to take up these interventions, or products, when they don’t cost anything. And certainly, free is better than expensive, but free is also a whole…
In the last few decades, medical schools have been teaching us doctors to inform patients about their treatment alternatives, so our patients can pick the alternative that best fits with their individual values. Which raises the question: Should doctors take the time to figure out the cost of treatment alternatives and communicate such information to…
My visit to this well-intentioned dermatologist illustrates one of the flaws of this idea of consumer empowerment.
American healthcare is ridiculously expensive.
“I can fix this.” The neurosurgeon was nothing if not confident. “The cyst is pushing on your spinal cord. If it continues to expand, it will damage your nerves and you may lose the ability to walk. But I can remove the cyst, and cure you.” The patient was a business school professor, a man…